Recent clinical study by Yamanaka et al., suggested that the high expression of CD13 in HCC patients was significantly associated with early recurrence, and hence poor prognosis of patients as well as shorter survival [11]. The gene discussed is ANPEP; the disease is hepatocellular carcinoma.